Mechanisms of Severe Mortality-Associated Bacterial Co-infections Following Influenza Virus Infection

被引:82
作者
Jia, Leili [1 ]
Xie, Jing [1 ]
Zhao, Jiangyun [1 ]
Cao, Dekang [2 ]
Liang, Yuan [1 ]
Hou, Xuexin [3 ]
Wang, Ligui [1 ]
Li, Zhenjun [3 ]
机构
[1] Chinese Peoples Liberat Army, Inst Dis Control & Prevent, Beijing, Peoples R China
[2] Chinese Peoples Armed Police Forces, Ctr Dis Control & Prevent, Beijing, Peoples R China
[3] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China
来源
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY | 2017年 / 7卷
基金
中国国家自然科学基金;
关键词
co-infection; influenza; bacteria; resumption of function; tolerance; mortality; RESPIRATORY-TRACT INFECTION; ACTIVATING-FACTOR RECEPTOR; STREPTOCOCCUS-PNEUMONIAE; STAPHYLOCOCCUS-AUREUS; A VIRUS; I INTERFERONS; PNEUMOCOCCAL INFECTION; MENINGOCOCCAL DISEASE; ALVEOLAR MACROPHAGES; PANDEMIC INFLUENZA;
D O I
10.3389/fcimb.2017.00338
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Influenza virus infection remains one of the largest disease burdens on humans. Influenza-associated bacterial co-infections contribute to severe disease and mortality during pandemic and seasonal influenza episodes. The mechanisms of severe morbidity following influenza bacteria co-infections mainly include failure of an antibacterial immune response and pathogen synergy. Moreover, failure to resume function and tolerance might be one of the main reasons for excessive mortality. In this review, recent advances in the study of mechanisms of severe disease, caused by bacterial co-infections following influenza virus pathogenesis, are summarized. Therefore, understanding the synergy between viruses and bacteria will facilitate the design of novel therapeutic approaches to prevent mortality associated with bacterial co-infections.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Influenza virus and factors that are associated with ICU admission, pulmonary co-infections and ICU mortality
    Beumer, M. C.
    Koch, R. M.
    van Beuningen, D.
    OudeLashof, A. M.
    van de Veerdonk, F. L.
    Kolwijck, E.
    van der Hoeven, J. G.
    Bergmans, D. C.
    Hoedemaekers, C. W. E.
    JOURNAL OF CRITICAL CARE, 2019, 50 : 59 - 65
  • [2] The impact of bacterial and viral co-infection in severe influenza
    Blyth, Christopher C.
    Webb, Steve A. R.
    Kok, Jen
    Dwyer, Dominic E.
    van Hal, Sebastiaan J.
    Foo, Hong
    Ginn, Andrew N.
    Kesson, Alison M.
    Seppelt, Ian
    Iredell, Jonathan R.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2013, 7 (02) : 168 - 176
  • [3] The impacts of bacterial co-infections and secondary bacterial infections on patients with severe influenza pneumonitis admitted to the intensive care units
    Lee, Wei-Chun
    Ho, Meng -Chin
    Leu, Shaw-Woei
    Chang, Che-Chia
    Lin, Chin-Kuo
    Lin, Chieh-Mo
    Fang, Yu -Hung
    Huang, Shu-Yi
    Lin, Yu -Ching
    Chuang, Min -Chun
    Yang, Tsung-Ming
    Hung, Ming-Szu
    Chou, Yen -Li
    Tsai, Ying-Huang
    Hsieh, Meng-Jer
    JOURNAL OF CRITICAL CARE, 2022, 72
  • [4] Bacterial and viral co-infections complicating severe influenza: Incidence and impact among 507 US patients, 2013-14
    Shah, Nirav S.
    Greenberg, Jared A.
    McNulty, Moira C.
    Gregg, Kevin S.
    Riddell, James
    Mangino, Julie E.
    Weber, Devin M.
    Hebert, Courtney L.
    Marzec, Natalie S.
    Barron, Michelle A.
    Chaparro-Rojas, Fredy
    Restrepo, Alejandro
    Hemmige, Vagish
    Prasidthrathsint, Kunatum
    Cobb, Sandra
    Herwaldt, Loreen
    Raabe, Vanessa
    Cannavino, Christopher R.
    Hines, Andrea Green
    Bares, Sara H.
    Antiporta, Philip B.
    Scardina, Tonya
    Patel, Ursula
    Reid, Gail
    Mohazabnia, Parvin
    Kachhdiya, Suresh
    Binh-Minh Le
    Park, Connie J.
    Ostrowsky, Belinda
    Robicsek, Ari
    Smith, Becky A.
    Schied, Jeanmarie
    Bhatti, Micah M.
    Mayer, Stockton
    Sikka, Monica
    Murphy-Aguilu, Ivette
    Patwari, Priti
    Abeles, Shira R.
    Torriani, Francesca J.
    Abbas, Zainab
    Toya, Sophie
    Doktor, Katherine
    Chakrabarti, Anindita
    Doblecki-Lewis, Susanne
    Looney, David J.
    David, Michael Z.
    JOURNAL OF CLINICAL VIROLOGY, 2016, 80 : 12 - 19
  • [5] Bacterial co-infections and antimicrobial resistance associated with the Coronavirus Disease 2019 infection
    Teklemariam, Addisu D.
    Hashem, Anwar M.
    Saber, Saber H.
    Almuhayawi, Mohammed S.
    Haque, Shafiul
    Abujamel, Turki S.
    Harakeh, Steve
    BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, 2023, 39 (02) : 259 - 280
  • [6] Viral co-infections are associated with increased rates of hospitalization in those with influenza
    Shannon, Kerry L.
    Osula, Valerie O.
    Shaw-Saliba, Kathryn
    Hardick, Justin
    McBryde, Breana
    Dugas, Andrea
    Hsieh, Yu-Hsiang
    Hansoti, Bhakti
    Rothman, Richard E.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2022, 16 (04) : 780 - 788
  • [7] Secondary Bacterial Infections in Influenza Virus Infection Pathogenesis
    Smith, Amber M.
    McCullers, Jonathan A.
    INFLUENZA PATHOGENESIS AND CONTROL - VOL I, 2014, 385 : 327 - 356
  • [8] Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU
    Contou, Damien
    Claudinon, Aurore
    Pajot, Olivier
    Micaelo, Maite
    Longuet Flandre, Pascale
    Dubert, Marie
    Cally, Radj
    Logre, Elsa
    Fraisse, Megan
    Mentec, Herve
    Plantefeve, Gaetan
    ANNALS OF INTENSIVE CARE, 2020, 10 (01)
  • [9] Bacterial co-infections in community-acquired pneumonia caused by SARS-CoV-2, influenza virus and respiratory syncytial virus
    Hedberg, Pontus
    Johansson, Niclas
    Ternhag, Anders
    Abdel-Halim, Lina
    Hedlund, Jonas
    Naucler, Pontus
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [10] Bacterial co-infections in community-acquired pneumonia caused by SARS-CoV-2, influenza virus and respiratory syncytial virus
    Pontus Hedberg
    Niclas Johansson
    Anders Ternhag
    Lina Abdel-Halim
    Jonas Hedlund
    Pontus Nauclér
    BMC Infectious Diseases, 22